April 7, 2021 08:56 AM EDTUpdated 11:27 AM

Covid-19 roundup: AstraZeneca pauses vaccine trial for children as blood clot probe continues; EMA to investigate whether Sputnik V trials met GCP standards — report

Amber Tong

Nicole DeFeudis

Editor

Josh Sullivan

AstraZeneca and partners at Oxford University have halted dosing of their Covid-19 vaccine to children in a small clinical trial in the latest hiccup caused …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: AstraZeneca pauses vaccine trial for children as blood clot probe continues; EMA to investigate whether Sputnik V trials met GCP standards — report

Amber Tong

Nicole DeFeudis

Editor

Josh Sullivan

Sign up to read this article for free.

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runway

Norbert Bischofberger's time as Kronos CEO ends as biotech seeks new life

Acadia snaps up an essential tremor drug after field's summer setbacks

Recursion reduces workforce; Oxford Nanopore teams up with UK Biobank

Covid-19 roundup: As­traZeneca paus­es vac­cine tri­al for chil­dren as blood clot probe con­tin­ues; EMA to in­ves­ti­gate whether Sput­nik V tri­als met GCP stan­dards — re­port

Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: AstraZeneca pauses vaccine trial for children as blood clot probe continues; EMA to investigate whether Sputnik V trials met GCP standards — report